Docxter said:
MSK is the newly ACGME accredited one and the vast majority of the MSK fellowships are not ACGME approved. You also have to add the Endovascular Surgical Neuroradiology fellowship to the list of ACGME approved ones. The only possible advantage is that in the more established ACGME-approved ones (neuro, IR, peds, nucs) have a CAQ (certificate of added qualification) boards examination to demonstrate subspecialty status, if one choses to get it. Otherwise, no advantage.
Concerning CAQ specialties.
The downside to a CAQ specialty is shelling out the $3,000 to take the test and then having to recertify every 10 years.
The CAQ in interventional radiology may have been intended to help 'protect turf', but now has become a hassle. Case in point, Vascular surgeons and Interventional Cardiologists can get credentialed to perform renal and carotid artery stenting at hospitals. In many cases they learned the procedure from a weekend-long device manufacturerer-sponsored course. However for an interventional radiologist, without an IR CAQ, many hospitals won't credential them to perform the these procedures-- despite the fact that the IR is usually the most technically proficient.
Furthermore, if you don't have a CAQ its additional fodder for a plaintiff's attorney in the case of a suboptimal outcome.
Concerning ACGME vs Non-ACGME specialties:
The 'hot' general MRI fellowships are, in general, not ACGME accredited. The advantage of this is that one is not technically a 'fellow'. Rather, one is hired on at the 'instructor' level and you can negotiate a better salary than the going PGY6 rate.
However, as a Non-ACGME fellow, you are not protected by the 80 hour work rule which means they can overwork you. At the same time there are no restrictions to moonlighting. Furthermore, you may have to pay for benefits out of pocket, and since you are technically no longer in training, you will have to begin repayment of your loans.